In vivo studies with C3 knockout models confirmed reduced platelet aggregation and less venous and arterial thrombosis in mice [114,115], with the platelet activation mechanism subsequently demonstrated to be due to binding of C3a to the platelet C3a receptor (C3aR) [116]. Here, C3 is linked to Arterial thrombosis.